Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.

Deisenroth C, Thorner AR, Enomoto T, Perou CM, Zhang Y.

Mol Cell Biol. 2010 Aug;30(16):3981-93. doi: 10.1128/MCB.01284-09. Epub 2010 Jun 14.

2.

MDM2 and MDM4: p53 regulators as targets in anticancer therapy.

Toledo F, Wahl GM.

Int J Biochem Cell Biol. 2007;39(7-8):1476-82. Epub 2007 Apr 8. Review.

3.

[Significance of MDM2 protein in the cell cycle].

Szemraj J, RozpoŇĄczyk E, Bartkowiak J, Greger J, Oszajca K.

Postepy Biochem. 2005;51(1):44-51. Review. Polish.

PMID:
16209341
4.

Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review.

Shaikh MF, Morano WF, Lee J, Gleeson E, Babcock BD, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB.

Ann Clin Lab Sci. 2016 Dec;46(6):627-634. Review.

PMID:
27993876
5.

microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network.

Hoffman Y, Pilpel Y, Oren M.

J Mol Cell Biol. 2014 Jun;6(3):192-7. doi: 10.1093/jmcb/mju020. Review.

6.

Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Wickramasekera NT, Das GM.

Mitochondrion. 2014 May;16:26-37. doi: 10.1016/j.mito.2013.10.002. Epub 2013 Oct 29. Review.

7.

MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53.

Sun W, Tang L.

Curr Med Chem. 2016;23(40):4529-4539. Review.

PMID:
27686656
8.

The role of MDM2 and MDM4 in breast cancer development and prevention.

Haupt S, Vijayakumaran R, Miranda PJ, Burgess A, Lim E, Haupt Y.

J Mol Cell Biol. 2017 Feb 1;9(1):53-61. doi: 10.1093/jmcb/mjx007. Review.

Supplemental Content

Support Center